Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Psychedelic/Assisted Therapies Recent news which mentions Psychedelic/Assisted Therapies < Previous 1 2 3 4 5 6 7 8 9 ... 14 15 Next > Congress Halts Hearing On Psychedelics & Veterans As House Speaker Drama Continues October 20, 2023 Tags Psychedelic/Assisted Therapies FDA Benzinga From Benzinga New Survey Suggests Psilocybin Eases Psychological Distress From Childhood Trauma October 19, 2023 Tags Psychedelics Psychological Distress Childhood trauma From Benzinga EXCLUSIVE: Reason For Hope On Veteran Group Efforts, Comments To FDA & 2023 Expectations October 18, 2023 Tags Ret/ Marine LtGen Martin Steele Exclusives Markets From Benzinga Lucy Scientific's Fiscal Year: Operating Expenses Rise As Accumulated Deficit Hits Over $44M October 17, 2023 Tickers LSDI Tags Psychedelics fiscal year results News From Benzinga Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More October 16, 2023 Tickers ATAI CMPS CYBN DMTTF Tags Small Cap U/S/ Food and Drug Administration Kratom From Benzinga U.K.'s Prof. David Nutt Ranked World's Top Psychopharmacologist: More On His Contributions & Advocacy October 15, 2023 Tickers AWKNF Tags Imperial College London Psychedelic/Assisted Therapies Benzinga From Benzinga Dem Presidential Candidate Calls For Universal Healthcare, Including Psychedelics Therapy October 13, 2023 Tags Market News Cannabis Psychedelic/Assisted Therapies From Benzinga Cybin And Small Pharma Shareholders Green Light Acquisition Resolution: Results & Expected Dates October 13, 2023 Tickers CYBN DMTTF Tags Acquisitions Contracts Psychedelics From Benzinga Pioneering Hope: Inside The Veteran's Organization Advancing Psychedelics Reform Policy October 12, 2023 Tags Benzinga FDA Global From Benzinga EXCLUSIVE: Understanding Real Estate For Psychedelic Treatments Boosted By Geospatial Mapping October 07, 2023 Tickers AAPL IBM Tags Management Tyler Zakovich News From Benzinga EXCLUSIVE: The Need To Enhance Psychedelic Therapy Infrastructure, Data-Driven Solutions October 06, 2023 Tags Psychedelic/Assisted Therapies Benzinga HealingMaps From Benzinga Maine's Portland Leads Drug Policy Reform, Decriminalizing Psychedelic Plants And Fungi October 04, 2023 Tags Management Psychedelics Legal From Benzinga Decoding Insurance Reimbursement For Psychedelic-Assisted Therapy With BrainFutures Guide October 04, 2023 Tags Psychedelics News Benzinga From Benzinga Atai Life Sciences Completes Phase 1 Clinical Study Of Oral Film DMT Formulation October 03, 2023 Tickers ATAI Tags Cannabis Market News Benzinga From Benzinga Cybin Completes Dosing In Phase 2 Study Of CYB003 For Major Depressive Disorder Treatment October 03, 2023 Tickers CYBN Tags Psychedelic/Assisted Therapies Penny Stocks Benzinga From Benzinga Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares October 03, 2023 Tickers BNOX CYBN MRK Tags News BNOX CYBN From Benzinga Insider's Look At Psychedelics Industry On Risk Management, Gray Market & Cannabis Industry October 03, 2023 Tags AlphaRoot Exclusives Markets From Benzinga GH Research's Psychedelic Drug Candidate For Depression Meets FDA: Clinical Program On Hold October 02, 2023 Tickers GHRS Tags Psychedelic/Assisted Therapies GHRS Benzinga From Benzinga Gov Newsom Green Lights Medical Psychedelics If Rescheduled And New Marijuana Testing Rules October 02, 2023 Tags Psychedelics Psychedelic/Assisted Therapies Benzinga From Benzinga Psychedelic Therapy Providers: Risk Management Perspective From A Cannabis Insurance Specialist October 02, 2023 Tags Psychedelics Market News Cannabis From Benzinga Argentina's Nacho Bottinelli On Psychedelics In Latin America: 'Brazil Opened A Giant Portal To Me' October 02, 2023 Tags Psychedelic/Assisted Therapies Brazil Psychedelics Ignacio Bottinelli From Benzinga Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More October 02, 2023 Tickers ATAI CMPS CYBN DMTTF Tags DMTTF ENVB Markets From Benzinga Psychedelics Reform Update: Massachusetts, Pennsylvania, Maine, California, Michigan, Minnesota, Indiana September 30, 2023 Tags Psychedelics Rumors Benzinga From Benzinga PharmaTher Is 'One Step Closer To Being A Ketamine Leader' Due To FDA Acceptance September 27, 2023 Tickers PHRRF Tags News General Guidance From Benzinga Cybin And Fluence Partner To Support EMBARK Training For Phase 3 CYB003 Trial For Depression September 26, 2023 Tickers CYBN Tags Contracts Psychedelic Therapists Training Psychedelics From Benzinga Depression Relief: Possible Therapy Boost With DMT & SSRIs, Per Small Pharma Clinical Results September 26, 2023 Tickers CYBN DMTTF Tags CYBN Management News From Benzinga Defense Dept. Grants $1M To Yale & Transcend Therapeutics To Study PTSD Therapy September 26, 2023 Tags News Department of Defense Psychedelics From Benzinga Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More September 26, 2023 Tickers ATAI CMPS CYBN DMTTF Tags GHRS Psychedelics Financing NKE From Benzinga Microdosing Unveiled: Expert's Take On The Practice's Ups & Downs September 24, 2023 Tickers META Tags Exclusives Psilocybin Microdosing Markets From Benzinga Cybin Delivers Highest Dose Of Psilocybin Analog In Phase 2 For Major Depression September 21, 2023 Tickers CYBN DMTTF Tags Psychedelic/Assisted Therapies Penny Stocks Psilocybin program From Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 14 15 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.